{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:22:00Z","timestamp":1761168120903,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Spanish Fundaci\u00f3n Mutua Madrile\u00f1a"},{"name":"Spanish Fundaci\u00f3n Eugenio Rodr\u00edguez Pascual"},{"name":"Spanish Institute of Health Carlos III"},{"name":"European FEDER","award":["PI15\/01951"],"award-info":[{"award-number":["PI15\/01951"]}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01951"],"award-info":[{"award-number":["PI15\/01951"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"University of Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ymgme.2018.12.009","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T03:39:32Z","timestamp":1545363572000},"page":"367-375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model"],"prefix":"10.1016","volume":"128","author":[{"given":"Diego","family":"Vera-Yunca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irantzu","family":"Serrano-Mendioroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Jeric\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1aki F.","family":"Troc\u00f3niz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Fontanellas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zinnia P.","family":"Parra-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.12.009_bb0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.clinre.2015.05.009","article-title":"Porphyrias: a 2015 update","volume":"39","author":"Karim","year":"2015","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(09)61925-5","article-title":"Porphyrias","volume":"375","author":"Puy","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2008-1040702","article-title":"Hematin therapy for the porphyric attack","volume":"2","author":"Pierach","year":"1982","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0025","first-page":"165","article-title":"Acute attacks of hepatic porphyria: specific treatment with heme arginate","volume":"144","author":"Nordmann","year":"1993","journal-title":"Ann. Med. Interne"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0030","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/archinte.1993.00410170078008","article-title":"Early administration of heme arginate for acute porphyric attacks","volume":"153","author":"Mustajoki","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0035","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(89)92688-3","article-title":"Controlled trial of haem arginate in acute hepatic porphyria","volume":"1","author":"Herrick","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0140-6736(78)92217-1","article-title":"Prevention of acute porphyric attacks by intravenous haematin","volume":"2","author":"Lamon","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0045","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(88)80092-5","article-title":"Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteers","volume":"85","author":"Simionatto","year":"1988","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1432-1033.1988.tb13811.x","article-title":"Human heme oxygenase cDNA and induction of its mRNA by hemin","volume":"171","author":"Yoshida","year":"1988","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0055","first-page":"0","article-title":"Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver","author":"Schmitt","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0060","first-page":"57","article-title":"Audit of the use of regular haem arginate infusions in patients with acute porphyria to prevent recurrent symptoms","volume":"22","author":"Marsden","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0065","series-title":"Int. Congr. Porphyrins and Porphyrias, Bordeaux","article-title":"EXPLORE: a prospective, multinational, natural history study of patients with Acute Hepatic Porphyrias (AHP) with recurrent attacks","author":"Sardh","year":"2017"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng0296-195","article-title":"Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria","volume":"12","author":"Lindberg","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0075","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jhep.2009.09.003","article-title":"Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria","volume":"52","author":"Unzu","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0080","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/dmd.116.073601","article-title":"Phenobarbital treatment at a neonatal age results in decreased efficacy of omeprazole in adult mice","volume":"45","author":"Tien","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0085","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/clinchem\/34.2.345","article-title":"A rapid and accurate spectrofluorometric method for quatification and screening of urinary porphyrins","volume":"34","author":"Westerlund","year":"1988","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/TACG.S48605","article-title":"An update of clinical management of acute intermittent porphyria","author":"Pischik","year":"2015","journal-title":"Appl. Clin. Genet."},{"year":"2009","series-title":"NONMEM\u2019s User's Guides","author":"Bauer","key":"10.1016\/j.ymgme.2018.12.009_bb0095"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0100","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/278536","article-title":"Biology of heme in mammalian erythroid cells and related disorders","volume":"2015","author":"Fujiwara","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0105","first-page":"1","article-title":"Systemic messenger RNA as an etiological treatment for acute intermittent porphyria","author":"Jiang","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00497022","article-title":"Pharmacokinetics of phenobarbital and propylhexedrine after administration of barbexaclone in the mouse","volume":"324","author":"Iven","year":"1983","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0115","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF02294361","article-title":"Model selection and Akaike's Information Criterion (AIC): the general theory and its analytical extensions","volume":"52","author":"Bozdogan","year":"1987","journal-title":"Psychometrika"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0120","series-title":"Introd. to Popul. Pharmacokinet. Pharmacodyn. Anal. with Nonlinear Mix. Eff. Model., John Wiley & Sons, Inc, Hoboken, New Jersey","first-page":"90","author":"van der Graaf","year":"2014"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0125","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1038\/psp.2013.24","article-title":"Modeling and simulation Workbench for NONMEM: tutorial on Pirana, PsN, and Xpose","volume":"2","author":"Keizer","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0130","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","article-title":"Xpose - an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM","volume":"58","author":"Jonsson","year":"1998","journal-title":"Comput. Methods Prog. Biomed."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/psp.2013.56","article-title":"Tutorial: Application of ggplot2 to pharmacometric graphics","volume":"2","author":"Ito","year":"2013","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0140","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1053\/jhep.2001.24170","article-title":"Zinc mesoporphyrin represses induced hepatic 5-aminolevulinic acid synthase and reduces heme oxygenase activity in a mouse model of acute hepatic porphyria","volume":"33","author":"Schuurmans","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.ymgme.2018.12.009_bb0145","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2119\/2004-00002.Johansson","article-title":"Biochemical characterization of porphobilinogen deaminase\u2013deficient mice during phenobarbital induction of heme synthesis and the effect of enzyme replacement","volume":"9","author":"Johansson","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0150","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amjmed.2014.10.026","article-title":"Role of delta-aminolevulinic acid in the symptoms of acute porphyria","volume":"128","author":"Bissell","year":"2015","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0155","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/erm.2016.18","article-title":"Emerging therapies for acute intermittent porphyria","volume":"18","author":"Fontanellas","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1124\/jpet.117.240309","article-title":"Semimechanistic bone marrow exhaustion pharmacokinetic\/pharmacodynamic model for chemotherapy-induced cumulative neutropenia","volume":"362","author":"Henrich","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0165","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1007\/s11095-016-1917-1","article-title":"Population in vitro-in vivo correlation model linking gastrointestinal transit time, pH, and pharmacokinetics: itraconazole as a model drug","volume":"33","author":"Abuhelwa","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ymgme.2018.12.009_bb0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann. Intern. Med."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218305742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218305742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:28:00Z","timestamp":1761089280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218305742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1096719218305742"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.12.009","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational disease model of phenobarbital-induced acute attacks in an acute intermittent porphyria mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}